Medtronic Cancer Pain Study Underscores Focus On Infusion Pump Systems
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is looking to combination products incorporating infusion pump systems as another growth vehicle for the firm's top line going into the 2003 fiscal year that began May 1
You may also be interested in...
UK Device Alert Faults Medtronic SynchroMed Supplemental Drug Labeling
Medtronic's SynchroMed implantable drug pump poses medication error risk due to an inaccurate listing of intrathecal drugs, an Oct. 31 device alert by the UK's Medical Devices Agency indicates
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.